Prophase labs, inc. announces closing of public offering

Garden city, ny, jan. 21, 2021 (globe newswire) -- prophase labs, inc. (nasdaq: prph), a diversified medical science and technology company, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock at a public offering price of $12.50 per share, for gross proceeds of $37,500,000, before deducting underwriting discounts and commissions and offering expenses. in addition, prophase labs, inc. has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions.
PRPH Ratings Summary
PRPH Quant Ranking